Monogram Technologies Leads with Innovative Robotic Surgery
Experience a revolutionary leap in orthopedic surgery as Monogram Technologies Inc. (NASDAQ: MGRM) announces the world’s first fully autonomous saw-based robotic knee replacement surgery. This groundbreaking procedure took place in India, performed at the renowned Krishna Shalby Hospital, highlighting Monogram's commitment to advancing surgical technologies.
Transforming Patient Care with the mBôs TKA System
The procedure utilized Monogram's innovative mBôs Total Knee Arthroplasty (TKA) System, which is part of a multi-center clinical trial. The successful execution of this surgery marks a new era in robotic-assisted knee replacements, ensuring high precision and increased safety for patients.
The Milestone Achievement
Monogram's CEO, Benjamin Sexson, expressed pride over this significant breakthrough, stating that the procedure embodies years of dedicated effort from his team. During an intraoperative evaluation, the system demonstrated exceptional execution, indicating its potential to enhance orthopedic practices.
Dr. Douglas Unis, the founder, shared his excitement about the procedure's execution, highlighting how the system performed with remarkable ease and accuracy. He believes this technology is not merely a gimmick but could revolutionize how knee replacements are conducted.
Commitment to Safety and Effectiveness
Patient safety remains a paramount concern during the development of the mBôs TKA System. Kamran Shamaei, Chief Technical Officer at Monogram, emphasized that the system was designed to be the safest and most efficient robotic solution available, driving home the company's dedication to both innovation and patient care.
Collaborating for Excellence
Shalby Limited (NSE: SHALBY) is strategically partnering with Monogram to conduct the clinical investigation. This collaboration merges Shalby’s extensive experience in joint replacement surgeries with Monogram's cutting-edge technology.
Dr. Vikram Shah, the founder of Shalby Hospitals, expressed his admiration for Monogram's achievements and reinforced the hospital's mission to prioritize innovation in orthopedic medicine. With thousands of successful surgeries executed, he recognizes the profound impact that the mBôs system will have on patient outcomes.
Regulatory Recognition and Future Outlook
The U.S. Food and Drug Administration (FDA) recently granted 510(k) clearance for Monogram’s semi-autonomous TKA System, providing a robust regulatory framework that underlines its safety and efficacy.
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a leader in global medical technology, has also established a definitive agreement to acquire Monogram Technologies, further validating the company's groundbreaking advancements in robotic surgery.
About Monogram Technologies Inc.
Headquartered in Austin, Texas, Monogram Technologies Inc. (NASDAQ: MGRM) is an innovative robotics company focused on enhancing human health through advanced orthopedic solutions. The company is at the forefront of integrating AI, machine vision, and 3D printing technology to streamline the production of patient-optimized orthopedic implants.
Monogram is poised to reshape the landscape of orthopedic surgery, making significant strides towards a future where robotic assistance enhances precision, efficiency, and safety in surgical procedures.
Frequently Asked Questions
1. What is the significance of Monogram Technologies' surgery?
This surgery is groundbreaking as it marks the world’s first fully autonomous saw-based robotic knee replacement, showcasing advancements in robotic surgical procedures.
2. Where was the procedure conducted?
The procedure was performed at the Krishna Shalby Hospital in India, as part of a clinical trial evaluating Monogram's robotic system.
3. What does the mBôs TKA System offer?
The mBôs TKA System is designed to enhance the accuracy and safety of knee replacement surgeries, leveraging advanced robotics for optimal patient outcomes.
4. Who are Monogram’s partners in this project?
Shalby Limited is a strategic partner supporting the initiative in India, focusing on the effectiveness and safety of the Monogram TKA System.
5. What recognition has Monogram Technologies received?
Monogram has received 510(k) clearance from the FDA for its semi-autonomous TKA System, affirming its commitment to regulatory standards and patient safety.
